论文部分内容阅读
报道48例非小细胞肺癌（Ⅰ、Ⅱ期）术后生存情况。男27例，女21例。年龄42～76岁，平均62．5岁。手术期未输协组和输血组1、3、5年生存率分别为82．4％、58．8％、47．1％和85．7％、42．9％、38．1％，无显著差异。Ⅰ、Ⅱ期病人1、3、5年生存率分别为90．5％、61．9％、52．4％和74．1％、40．7％、29．6％，有显著差异。未发现肺癌病人手术期输血与未输血者在生存率之间有明显关系，但输血对生存的影响不能忽视，需在大范围内进行调查，细致随访。
Reported 48 cases of non-small cell lung cancer (I, II) postoperative survival. There were 27 males and 21 females. Age 42 to 76 years old, average 62.5 years old. The 1-, 3-, and 5-year survival rates of the untransfused group and the transfusion group were 82.4%, 58.8%, 47.1%, and 85.7%, 42.9%, and 38.1%, respectively. Significant differences. The 1-, 3-, and 5-year survival rates of stage I and II patients were 90.5%, 61.9%, 52.4%, and 74.1%, 40.7%, and 29.6%, respectively, with significant differences. No significant difference was found in the survival rate between patients with and without blood transfusion in lung cancer patients. However, the impact of blood transfusion on survival cannot be ignored. It is necessary to conduct investigations on a large scale and follow them carefully.